Position in AMGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$50,568,585
+$2,057,970 QoQ
Shares Held
143,722
-3.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. AMGN ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
This page
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,568,585 | 143,722 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $48,510,615 | 148,210 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $42,994,863 | 152,356 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $49,133,927 | 157,708 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $41,878,332 | 160,675 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $51,145,682 | 158,734 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $50,761,564 | 162,463 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $39,884,409 | 140,280 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $41,726,609 | 144,874 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $39,624,093 | 147,433 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $33,471,513 | 150,759 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $37,645,310 | 155,720 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $41,295,937 | 157,234 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $36,199,916 | 160,603 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $39,486,373 | 162,295 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $42,012,114 | 173,733 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $27,997,291 | 124,449 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $27,699,363 | 130,258 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $32,469,450 | 133,208 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $34,244,715 | 137,634 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $32,506,779 | 141,383 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $37,742,760 | 148,500 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $36,286,589 | 153,848 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $31,049,924 | 153,159 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||